{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:32:20Z","timestamp":1792668740822,"version":"4.5.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":3590,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1111\/ajt.12004","type":"journal-article","created":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T14:33:48Z","timestamp":1359038028000},"page":"41-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":286,"special_numbering":"S3","title":["Epstein\u2013Barr Virus Infection and Posttransplant Lymphoproliferative Disorder"],"prefix":"10.1016","volume":"13","author":[{"given":"M.","family":"Green","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.G.","family":"Michaels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 4","key":"10.1111\/ajt.12004_bib1","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1111\/j.1600-6143.2009.02898.x","article-title":"Epstein\u2013Barr virus and posttransplant lymphoproliferative disorder in solid organ transplant recipients","volume":"9","author":"Allen","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12004_bib2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","article-title":"Epstein\u2013Barr virus infection","volume":"343","author":"Cohen","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.12004_bib3","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0031-3955(03)00127-5","article-title":"Posttransplantation lymphoproliferative disorders","volume":"50","author":"Green","year":"2003","journal-title":"Pediatric clinics of North America"},{"key":"10.1111\/ajt.12004_bib4","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/j.1600-6143.2006.01394.x","article-title":"CMV-IVIG for prevention of Epstein Barr virus disease and posttransplant lymphoproliferative disease in pediatric liver transplant recipients","volume":"6","author":"Green","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12004_bib5","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/j.1600-6143.2006.01394.x","article-title":"CMV-IVIG for prevention of Epstein Barr virus disease and posttransplant lymphoproliferative disease in pediatric liver transplant recipients","volume":"6","author":"Green","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12004_bib6","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1600-6143.2011.03896.x","article-title":"Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: Report of the French registry and analysis of subgroups of lymphomas","volume":"12","author":"Caillard","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12004_bib7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.TP.0000165098.49658.F3","article-title":"Lymphoproliferative disease after renal transplantation in Australia and New Zealand","volume":"80","author":"Faull","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12004_bib8","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00007890-198804000-00011","article-title":"The frequency of Epstein\u2013Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children","volume":"45","author":"Ho","year":"1988","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12004_bib9","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/infdis\/152.5.876","article-title":"Epstein\u2013Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: The role of primary infection","volume":"152","author":"Ho","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1111\/ajt.12004_bib10","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2007-06-093278","article-title":"On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis","volume":"111","author":"Hadinoto","year":"2008","journal-title":"Blood"},{"key":"10.1111\/ajt.12004_bib11","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/MOT.0b013e328330680d","article-title":"Intestinal transplantation: Current outcomes and opportunities","volume":"14","author":"Mazariegos","year":"2009","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1111\/ajt.12004_bib12","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1111\/j.1600-6143.2006.01540.x","article-title":"Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: Report of 230 cases from the French Registry","volume":"6","author":"Caillard","year":"2006","journal-title":"Am J Transplant"},{"issue":"Pt 1","key":"10.1111\/ajt.12004_bib13","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1600-6143.2006.01294.x","article-title":"Post-transplant lymphoproliferative disorders following liver transplantation: Incidence, risk factors and survival","volume":"6","author":"Kremers","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12004_bib14","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: A collaborative transplant study report","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12004_bib15","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1200\/JCO.2009.25.4961","article-title":"Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: Outcomes and prognostic factors in the modern era","volume":"28","author":"Evens","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1111\/ajt.12004_bib16","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","article-title":"Virus particles in cultured lymphoblasts from Burkitt\u2019s lymphoma","volume":"1","author":"Epstein","year":"1964","journal-title":"Lancet"},{"key":"10.1111\/ajt.12004_bib17","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1038\/emboj.2012.63","article-title":"EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency","volume":"31","author":"Riley","year":"2012","journal-title":"EMBO J"},{"key":"10.1111\/ajt.12004_bib18","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.187.9.1395","article-title":"Direct visualization of antigen-specific CD8+ T-cells during the primary immune response to Epstein\u2013Barr virus in vivo","volume":"187","author":"Callan","year":"1998","journal-title":"J Exp Med"},{"key":"10.1111\/ajt.12004_bib19","series-title":"Post-Transplant Lymphoproliferative Disorders.","first-page":"29","article-title":"The biology of Epstein\u2013Barr virus and posttransplant lymphoproliferative disease","author":"Martinez","year":"2010"},{"key":"10.1111\/ajt.12004_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/10428199409051672","article-title":"EBV gene expression, EBNA antibody responses and EBV+ peripheral blood lymphocytes in post-transplant lymphoproliferative disease","volume":"15","author":"McKnight","year":"1994","journal-title":"Leukemia Lymphoma"},{"key":"10.1111\/ajt.12004_bib21","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/00007890-200205270-00014","article-title":"Ratio between Epstein\u2013Barr viral load and anti-Epstein\u2013Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease","volume":"73","author":"Smets","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12004_bib22","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.1182\/blood-2002-10-3001","article-title":"Impaired recovery of Epstein\u2013Barr virus (EBV)-specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease","volume":"101","author":"Meij","year":"2003","journal-title":"Blood"},{"key":"10.1111\/ajt.12004_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.trim.2005.02.001","article-title":"EBV-specific memory CD8+ T-cell phenotype and function in stable solid organ transplant patients","volume":"14","author":"Macedo","year":"2005","journal-title":"Transplant Immunol"},{"key":"10.1111\/ajt.12004_bib24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00007890-200208270-00012","article-title":"Identification of Epstein\u2013Barr virus-specific CD8+ T lymphocytes in the circulation of pediatric transplant recipients","volume":"74","author":"Falco","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12004_bib25","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1097\/00007890-199911270-00015","article-title":"Epstein\u2013Barr virus-induced posttransplant lymphoproliferative disorders. ASTS\/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting","volume":"68","author":"Paya","year":"1999","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12004_bib26","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJM199012203232502","article-title":"Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients","volume":"323","author":"Swinnen","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.12004_bib27","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/j.1600-6143.2007.01972.x","article-title":"Dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab","volume":"7","author":"Kirk","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12004_bib28","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1600-6143.2010.03016.x","article-title":"A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study)","volume":"10","author":"Durrbach","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12004_bib29","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/TP.0b013e3182007b95","article-title":"An integrated safety profile analysis of belatacept in kidney transplant recipients","volume":"90","author":"Grinyo","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12004_bib30","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":"A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)","volume":"10","author":"Vincenti","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12004_bib31","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1111\/j.1600-6143.2012.04011.x","article-title":"Molecular and clinicopathological analysis of Epstein\u2013Barr virus-associated posttransplant smooth muscle tumors","volume":"12","author":"Jonigk","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12004_bib32","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues.","article-title":"International Agency for Research on Cancer., World Health Organization","author":"Swerdlow","year":"2008"},{"key":"10.1111\/ajt.12004_bib33","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1111\/j.1600-6143.2012.04206.x","article-title":"Low-dose chemotherapy and rituximab for post-transplant disease (PTLD): A Children\u2019s Oncology Group report","volume":"12","author":"Gross","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12004_bib34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0022-3468(00)80003-2","article-title":"Long-term survival expectancy after liver transplantation in children","volume":"35","author":"Migliazza","year":"2000","journal-title":"J Pediatr Surg"},{"key":"10.1111\/ajt.12004_bib35","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/ppul.20025","article-title":"Mortality after pediatric lung transplantation: Autopsies vs. clinical impression","volume":"37","author":"Kaditis","year":"2004","journal-title":"Pediatr Pulmonol"},{"key":"10.1111\/ajt.12004_bib36","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/infdis\/166.5.986","article-title":"Quantitative oropharyngeal Epstein\u2013Barr virus shedding in renal and cardiac transplant recipients: Relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder","volume":"166","author":"Preiksaitis","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1111\/ajt.12004_bib37","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1182\/blood.V83.9.2715.2715","article-title":"Direct correlation between the load of Epstein\u2013Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease","volume":"83","author":"Savoie","year":"1994","journal-title":"Blood"},{"key":"10.1111\/ajt.12004_bib38","series-title":"Post-Transplant Lymphoproliferative Disorders.","first-page":"45","article-title":"Epstein\u2013Barr viral load testing: Role in the prevention, diagnosis and management of posttransplant lymphoproliferative disorders","author":"Preiksaitis","year":"2010"},{"key":"10.1111\/ajt.12004_bib39","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1034\/j.1399-3062.2001.003002079.x","article-title":"Epstein\u2013Barr virus load monitoring: Its role in the prevention and management of post-transplant lymphoproliferative disease","volume":"3","author":"Rowe","year":"2001","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/ajt.12004_bib40","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1128\/jcm.35.6.1612-1615.1997","article-title":"Use of quantitative competitive PCR to measure Epstein\u2013Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders","volume":"35","author":"Rowe","year":"1997","journal-title":"J Clin Microbiol"},{"key":"10.1111\/ajt.12004_bib41","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.1600-6143.2008.02183.x","article-title":"EBV PCR in the diagnosis and monitoring of posttransplant lymphoproliferative disorder: Results of a two-arm prospective trial","volume":"8","author":"Tsai","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12004_bib42","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1128\/JCM.41.11.5245-5249.2003","article-title":"Measurement of Epstein\u2013Barr virus DNA loads in whole blood and plasma by TaqMan PCR and in peripheral blood lymphocytes by competitive PCR","volume":"41","author":"Wadowsky","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1111\/ajt.12004_bib43","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1399-3046.2008.00918.x","article-title":"Increased Ig-null B lymphocytes in the peripheral blood of pediatric solid organ transplant recipients with elevated Epstein\u2013Barr viral loads","volume":"13","author":"Schauer","year":"2009","journal-title":"Pediatr Transplant"},{"key":"10.1111\/ajt.12004_bib44","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1600-6143.2008.02514.x","article-title":"Interlaboratory comparison of Epstein\u2013Barr virus viral load assays","volume":"9","author":"Preiksaitis","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12004_bib45","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-6143.2005.01207.x","article-title":"American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation","volume":"6","author":"Humar","year":"2006","journal-title":"Am J Transplant"},{"issue":"XXXX","key":"10.1111\/ajt.12004_bib46","first-page":"1","article-title":"Collaborative study to evaluate the proposed 1st WHO International Standard for Epstein\u2013Barr Virus (EBV) for nucleic acid amplification (NAT)-based assays","volume":"11","author":"Fryer JF","year":"2011","journal-title":"WHO ECBS Report"},{"issue":"Suppl","key":"10.1111\/ajt.12004_bib47","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1097\/01.tp.0000186382.81130.ba","article-title":"Malignancy after transplantation","volume":"80","author":"Buell","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12004_bib48","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1056\/NEJM198910193211604","article-title":"Expression of Epstein\u2013Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease","volume":"321","author":"Young","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.12004_bib49","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/TP.0b013e3181aacdd7","article-title":"The impact of EBV load on T-cell immunity in pediatric thoracic transplant recipients","volume":"88","author":"Macedo","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12004_bib50","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1399-0012.2006.00537.x","article-title":"Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high-risk for EBV infection","volume":"20","author":"Lee","year":"2006","journal-title":"Clin Transplant"},{"key":"10.1111\/ajt.12004_bib51","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(84)90994-2","article-title":"Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy","volume":"1","author":"Starzl","year":"1984","journal-title":"Lancet"},{"key":"10.1111\/ajt.12004_bib52","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1034\/j.1600-6143.2001.10202.x","article-title":"Management of Epstein\u2013Barr virus-induced post-transplant lymphoproliferative disease in recipients of solid organ transplantation","volume":"1","author":"Green","year":"2001","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12004_bib53","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1600-6143.2010.03387.x","article-title":"Reduction of immunosuppression as initial therapy for posttransplantation lymphoproliferative disorder (bigstar)","volume":"11","author":"Reshef","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12004_bib54","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM198204153061506","article-title":"Epstein\u2013Barr virus-induced B-cell lymphoma after renal transplantation: Acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation","volume":"306","author":"Hanto","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.12004_bib55","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/00365549950164409","article-title":"Acyclovir for treatment of infectious mononucleosis: A meta-analysis","volume":"31","author":"Torre","year":"1999","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/ajt.12004_bib56","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1097\/00007890-199812270-00006","article-title":"Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients","volume":"66","author":"McDiarmid","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12004_bib57","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1182\/blood-2006-01-024703","article-title":"A phase 1\/2 trial of arginine butyrate and ganciclovir in patients with Epstein\u2013Barr virus-associated lymphoid malignancies","volume":"109","author":"Perrine","year":"2007","journal-title":"Blood"},{"key":"10.1111\/ajt.12004_bib58","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.1182\/blood-2011-01-332379","article-title":"Bortezomib induction of C\/EBPbeta mediates Epstein\u2013Barr virus lytic activation in Burkitt lymphoma","volume":"117","author":"Shirley","year":"2011","journal-title":"Blood"},{"key":"10.1111\/ajt.12004_bib59","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1056\/NEJM198805193182013","article-title":"Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin","volume":"318","author":"Shapiro","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.12004_bib60","first-page":"2660","article-title":"Posttransplant lymphoproliferative disease after heart transplantation on Sandimmune therapy: Treatment with interferon alfa-2b and intravenous immunoglobulin","volume":"26","author":"Ippoliti","year":"1994","journal-title":"Transplantation Proc"},{"key":"10.1111\/ajt.12004_bib61","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/clinids\/20.5.1346","article-title":"Pretransplantation assessment of the risk of lymphoproliferative disorder","volume":"20","author":"Walker","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1111\/ajt.12004_bib62","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1182\/blood.V84.3.972.972","article-title":"Increased levels of circulating Epstein\u2013Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients","volume":"84","author":"Riddler","year":"1994","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1111\/ajt.12004_bib63","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/annonc\/11.suppl_1.S45","article-title":"Diagnosis and treatment of transplant-related lymphoma","volume":"11","author":"Swinnen","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1111\/ajt.12004_bib64","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1097\/01.tp.0000185570.41571.df","article-title":"Rituximab (chimeric anti-CD20 antibody) for posttransplant lymphoproliferative disorder after solid organ transplantation in adults: Long-term experience from a single center","volume":"80","author":"Jain","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12004_bib65","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1111\/j.1600-6143.2005.01098.x","article-title":"Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD)","volume":"5","author":"Oertel","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12004_bib66","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1182\/blood-2005-01-0377","article-title":"Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: Results of a prospective multicenter phase 2 study","volume":"107","author":"Choquet","year":"2006","journal-title":"Blood"},{"key":"10.1111\/ajt.12004_bib67","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00277-007-0298-2","article-title":"Rituximab in the management of post-transplantation lymphoproliferative disorder after solid organ transplantation: Proceed with caution","volume":"86","author":"Choquet","year":"2007","journal-title":"Ann Hematol"},{"key":"10.1111\/ajt.12004_bib68","doi-asserted-by":"crossref","first-page":"213a","DOI":"10.1182\/blood.V104.11.746.746","article-title":"Anti-CD20 monoclonal antibody (rituximab) for refractory PTLD after pediatric solid organ transplantation: Multicenter experience from a registry and from prospective clinical trial","volume":"104","author":"Webber","year":"2004","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1111\/ajt.12004_bib69","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/annonc\/11.suppl_1.S113","article-title":"Humanized anti-CD20 monoclonal antibody (rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients","volume":"11","author":"Milpied","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1111\/ajt.12004_bib70","doi-asserted-by":"crossref","first-page":"6481","DOI":"10.1200\/JCO.2005.08.074","article-title":"Low-dose chemotherapy for Epstein\u2013Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation","volume":"23","author":"Gross","year":"2005","journal-title":"J Clin Oncol"},{"issue":"Pt 2","key":"10.1111\/ajt.12004_bib71","first-page":"3945S","article-title":"A pilot study of chemoimmunotherapy (cyclophosphamide, prednisone, and rituximab) in patients with post-transplant lymphoproliferative disorder following solid organ transplantation","volume":"9","author":"Orjuela","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1111\/ajt.12004_bib72","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1470-2045(11)70300-X","article-title":"Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): The prospective international multicentre phase 2 PTLD-1 trial","volume":"13","author":"Trappe","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1111\/ajt.12004_bib73","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/cncr.24834","article-title":"Primary central nervous system post-transplantation lymphoproliferative disorder: An International Primary Central Nervous System Lymphoma Collaborative Group Report","volume":"116","author":"Cavaliere","year":"2010","journal-title":"Cancer"},{"key":"10.1111\/ajt.12004_bib74","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bcmd.2007.06.020","article-title":"T-cell therapy of Epstein\u2013Barr virus and adenovirus infections after hemopoietic stem cell transplant","volume":"40","author":"Comoli","year":"2008","journal-title":"Blood Cells Mol Dis"},{"key":"10.1111\/ajt.12004_bib75","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1182\/blood-2006-05-021782","article-title":"Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs)","volume":"108","author":"Savoldo","year":"2006","journal-title":"Blood"},{"key":"10.1111\/ajt.12004_bib76","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/CJI.0b013e318181b4bd","article-title":"Exploiting cytokine secretion to rapidly produce multivirus-specific T-cells for adoptive immunotherapy","volume":"31","author":"Fujita","year":"2008","journal-title":"J Immunother"},{"key":"10.1111\/ajt.12004_bib77","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1111\/j.1600-6143.2006.01429.x","article-title":"Successful in vitro priming of EBV-specific CD8+ T-cells endowed with strong cytotoxic function from T-cells of EBV-seronegative children","volume":"6","author":"Comoli","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12004_bib78","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2006-12-063008","article-title":"Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: Results of a phase 2 multicenter clinical trial","volume":"110","author":"Haque","year":"2007","journal-title":"Blood"},{"key":"10.1111\/ajt.12004_bib79","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/TP.0b013e3181d7c424","article-title":"Allogeneic T-cell therapy for Epstein\u2013Barr virus-positive posttransplant lymphoproliferative disease: Long-term follow-up","volume":"90","author":"Haque","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12004_bib80","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1128\/JVI.01409-07","article-title":"Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis","volume":"82","author":"Elliott","year":"2008","journal-title":"J Virol"},{"key":"10.1111\/ajt.12004_bib81","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/523813","article-title":"Recombinant gp350 vaccine for infectious mononucleosis: A phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein\u2013Barr virus vaccine in healthy young adults","volume":"196","author":"Sokal","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1111\/ajt.12004_bib82","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1016\/j.vaccine.2007.04.008","article-title":"Phase I\/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein\u2013Barr virus vaccine in healthy adults","volume":"25","author":"Moutschen","year":"2007","journal-title":"Vaccine"},{"key":"10.1111\/ajt.12004_bib83","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/TP.0b013e3181b9d918","article-title":"A phase I trial of Epstein\u2013Barr virus gp350 vaccine for children with chronic kidney disease awaiting transplantation","volume":"88","author":"Rees","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12004_bib84","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/(SICI)1097-0215(19970516)71:4<624::AID-IJC19>3.0.CO;2-B","article-title":"Preventive effect of IgG from EBV-seropositive donors on the development of human lympho-proliferative disease in SCID mice","volume":"71","author":"Abedi","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1111\/ajt.12004_bib85","first-page":"223","article-title":"Human immunoglobulin preparations suppress the occurrence of Epstein\u2013Barr virus-associated lymphoproliferation","volume":"25","author":"Nadal","year":"1997","journal-title":"Exp Hematol"},{"key":"10.1111\/ajt.12004_bib86","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(95)91150-2","article-title":"Use of gene-modified virus-specific T lymphocytes to control Epstein\u2013Barr virus-related lymphoproliferation","volume":"345","author":"Rooney","year":"1995","journal-title":"Lancet"},{"key":"10.1111\/ajt.12004_bib87","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/01.tp.0000252784.60159.96","article-title":"Epstein\u2013Barr virus-DNA load monitoring late after lung transplantation: A surrogate marker of the degree of immunosuppression and a safe guide to reduce immunosuppression","volume":"83","author":"Bakker","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12004_bib88","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1182\/blood-2006-05-021782","article-title":"Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs)","volume":"108","author":"Savoldo","year":"2006","journal-title":"Blood"},{"key":"10.1111\/ajt.12004_bib89","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/00007890-199509270-00005","article-title":"Epstein\u2013Barr virus DNA in peripheral blood leukocytes of patients with posttransplant lymphoproliferative disease","volume":"60","author":"Kenagy","year":"1995","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12004_bib90","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1053-2498(01)00407-7","article-title":"Anti-viral prophylaxis reduces the incidence of lymphoproliferative disease in lung transplant recipients","volume":"21","author":"Malouf","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/ajt.12004_bib91","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1111\/j.1600-6143.2005.01115.x","article-title":"Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients","volume":"5","author":"Funch","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12004_bib92","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/01.tp.0000202724.07714.a2","article-title":"A randomized trial of ganciclovir versus ganciclovir plus immune globulin for prophylaxis against Epstein\u2013Barr virus related posttransplant lymphoproliferative disorder","volume":"81","author":"Humar","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12004_bib93","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s004670050692","article-title":"Posttransplant lymphoproliferative disorder in pediatric renal transplantation","volume":"13","author":"Srivastava","year":"1999","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/ajt.12004_bib94","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1111\/j.1600-6143.2005.01002.x","article-title":"Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients","volume":"5","author":"Lee","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12004_bib95","first-page":"198","article-title":"Low-dose immunosuppression reduces the incidence of post-transplant lymphoproliferative disease in pediatric liver graft recipients","volume":"38","author":"Ganschow","year":"2004","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1111\/ajt.12004_bib96","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/j.1600-6143.2011.03478.x","article-title":"Monitoring infection with Epstein\u2013Barr virus among seromismatch adult renal transplant recipients","volume":"11","author":"Martin","year":"2011","journal-title":"Am J Transplant"},{"issue":"Suppl 1","key":"10.1111\/ajt.12004_bib97","first-page":"1","article-title":"OPaTNOaSRoTR. SRTR 2010 Annual Data Report. Department of Health and Human Services, Health Resources and Services Administration, HealthCare Systems Bureau, Division of Transplantation","volume":"12","year":"2012","journal-title":"Am J Transplant"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.12004","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522262509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522262509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:01:50Z","timestamp":1761627710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522262509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":97,"alternative-id":["S1600613522262509"],"URL":"https:\/\/doi.org\/10.1111\/ajt.12004","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epstein\u2013Barr Virus Infection and Posttransplant Lymphoproliferative Disorder","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.12004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}